These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37988189)

  • 1. Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients.
    He JR; Li D; Zhang QX; Liu T; Ding Y; Wu CY; Chen SS; Chen JL
    Aging (Albany NY); 2023 Nov; 15(22):13265-13286. PubMed ID: 37988189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of KLRB1 is associated with increased cell growth, metastasis, poor prognosis, as well as a dysfunctional immune microenvironment in LUAD.
    Chen JL; Wu CY; Luo XY; Wang XY; Wang FM; Huang X; Yuan W; Guo Q
    Sci Rep; 2024 May; 14(1):11782. PubMed ID: 38782996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning immune-related gene based on KLRB1 model for predicting the prognosis and immune cell infiltration of breast cancer.
    Huang G; Xiao S; Jiang Z; Zhou X; Chen L; Long L; Zhang S; Xu K; Chen J; Jiang B
    Front Endocrinol (Lausanne); 2023; 14():1185799. PubMed ID: 37351109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low expression of
    Liu X; Cui Q; Qin N
    Transl Cancer Res; 2024 Mar; 13(3):1225-1240. PubMed ID: 38617516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma.
    Ling J; Peng N; Luo L
    J Clin Lab Anal; 2022 Jun; 36(6):e24362. PubMed ID: 35373393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing the role of BRCA1 in the diagnosis, prognosis and immune infiltrates of breast invasive cancer by bioinformatics analysis and experimental validation.
    Li L; Li S; Zhang X; Mei L; Fu X; Dai M; Wei N
    Aging (Albany NY); 2024 Jan; 16(2):1077-1095. PubMed ID: 38224491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of KLRB1 and its further association with immune cells in breast cancer.
    Xu N; Meng X; Chu H; Yang Z; Jiao Y; Li Y
    PeerJ; 2023; 11():e15654. PubMed ID: 37520246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.
    Song C; Shang F; Tu W; Liu X
    BMC Cancer; 2023 Mar; 23(1):296. PubMed ID: 37004015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the role of KLRB1: a novel prognostic indicator in hepatocellular carcinoma.
    Fang S; Zhou Y
    BMC Gastroenterol; 2024 Jun; 24(1):210. PubMed ID: 38914941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer.
    Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D
    BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors.
    Cheng X; Cao Y; Wang X; Cheng L; Liu Y; Lei J; Peng W; Shi D
    J Immunol Res; 2022; 2022():5254911. PubMed ID: 35028320
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Liang C; Chen Y; Chen S; She J; Shi Q; Wang P
    Transl Cancer Res; 2023 Dec; 12(12):3641-3652. PubMed ID: 38192989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polo-like kinase 1 as a biomarker predicts the prognosis and immunotherapy of breast invasive carcinoma patients.
    Shen J; Zhang W; Jin Q; Gong F; Zhang H; Xu H; Li J; Yao H; Jiang X; Yang Y; Hong L; Mei J; Song Y; Zhou S
    Oncol Res; 2023; 32(2):339-351. PubMed ID: 38186570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
    Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
    Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
    Xiao R; Yang M; Tan Y; Ding R; Li D
    Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironment.
    Zhu Z; Ye W; Wu X; Lin S; Xu J; Li L; Li J; Wang H; Huang Z
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33350431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calreticulin, a potential coregulator of immune checkpoints and biomarker associated with tumor microenvironment and clinical prognostic significance in breast invasive carcinoma.
    Lin J; Chen Y; Zhang Z; Qi F; Zhang M
    Environ Toxicol; 2024 May; 39(5):2717-2731. PubMed ID: 38247288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer.
    Chen F; Han B; Meng Y; Han Y; Liu B; Zhang B; Chang Y; Cao P; Fan Y; Tan K
    Aging (Albany NY); 2021 Aug; 13(16):20438-20467. PubMed ID: 34413268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression patterns associated with tumor-infiltrating CD4+ and CD8+ T cells in invasive breast carcinomas.
    Wang Z; Yang X; Shen J; Xu J; Pan M; Liu J; Han S
    Hum Immunol; 2021 Apr; 82(4):279-287. PubMed ID: 33612391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.